Acute Coronary Syndrome KCMC
Community and Physician Perceptions of Chest Pain and Prevalence of Acute Coronary Syndrome Among HIV-infected and -Uninfected Patients in Moshi, Tanzania
1 other identifier
interventional
641
1 country
1
Brief Summary
The purpose of this study is to develop a quality improvement intervention to address barriers to evidence-based acute coronary syndrome (ACS) care in northern Tanzania. Patients who presented to Kilimanjaro Christian Medical Center (KCMC) will be asked to complete a survey about barriers and facilitators of health care. In addition the survey will be administered to all providers, policymakers, and administrators participating in in-depth interviews. Data from this survey will be used to develop a quality improvement intervention that will be piloted by KCMC staff. Six months after the pilot program is implemented providers, patients, and administrators will be interviewed for their perspectives on the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2020
CompletedFirst Posted
Study publicly available on registry
September 24, 2020
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedResults Posted
Study results publicly available
January 31, 2025
CompletedJanuary 31, 2025
December 1, 2024
1 year
September 21, 2020
December 23, 2024
December 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Acceptability as Measured by the Acceptability of Intervention Measure (AIM)
The AIM tool is a 4-question survey that evaluates the acceptability of an intervention. Responses to each question are on a 5-point Likert Scale (Strongly Agree=5, Agree=4, Neutral=3, Disagree=2, Strongly Disagree=1). Responses of "Strongly Agree" (5) and "Agree" (4) are considered to indicate a more acceptable intervention. The responses to each question will be averaged together to give an acceptability score between 1 and 5 for each respondent. The primary outcome will be the overall mean acceptability score among respondents. A mean acceptability score \>= 4 will be considered to indicate acceptability.
Initial ED visit (baseline)
Secondary Outcomes (4)
Number of Participants Presenting With Chest Pain or Shortness of Breath Who Undergo ECG and Cardiac Biomarker Testing During Their ED Stay
Initial ED visit (baseline)
Survival of Participants With Acute Coronary Syndrome (ACS) at 30 Days After Enrollment
30 days after enrollment
Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin at Baseline
Initial ED visit (baseline)
Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin 30 Days After Enrollment
30 days after enrollment
Study Arms (1)
MI Patients in northern Tanzania
OTHERPatients presenting to KCMC emergency department with acute MI
Interventions
A quality improvement intervention including reminders, care protocols, and text messages to improve care of myocardial infarction in the KCMC ED
Eligibility Criteria
You may qualify if:
- years or older
- symptoms related to acute coronary syndrome
- myocardial infarction
- clinically sober
- able to communicate in Swahili or English
You may not qualify if:
- medically unstable
- have a deteriorating condiction
- too critically ill to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Hospital
Durham, North Carolina, 27710, United States
Related Publications (3)
Hertz JT, Nworie JE, Shayo F, Galson SW, Coaxum LA, Daniel I, Makambay PS, Akrabi AM, Manyangu GJ, Thielman NM, Bloomfield G, Sakita FM. Acute myocardial infarction diagnosis and treatment following implementation of a multicomponent intervention in Tanzania: the MIMIC pilot trial. BMJ Open. 2025 Nov 11;15(11):e107857. doi: 10.1136/bmjopen-2025-107857.
PMID: 41218933DERIVEDHertz JT, Sakita FM, Haukila KF, Shayo PS, Shayo FM, Willy J, Lameck G, Kisanga E, Bosworth HB, Bettger JP, Rahim FO. Acceptability and Feasibility of a Multicomponent Intervention to Improve Acute Myocardial Infarction Care in Northern Tanzania: the MIMIC Pilot Trial. medRxiv [Preprint]. 2024 Dec 16:2024.12.13.24319026. doi: 10.1101/2024.12.13.24319026.
PMID: 39763513DERIVEDHertz JT, Sakita FM, Rahim FO, Mmbaga BT, Shayo F, Kaboigora V, Mtui J, Bloomfield GS, Bosworth HB, Bettger JP, Thielman NM. Multicomponent Intervention to Improve Acute Myocardial Infarction Care in Tanzania: Protocol for a Pilot Implementation Trial. JMIR Res Protoc. 2024 Sep 24;13:e59917. doi: 10.2196/59917.
PMID: 39316783DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Julian T. Hertz, MD
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Julian Hertz, MD
Duke University Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2020
First Posted
September 24, 2020
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
October 1, 2024
Last Updated
January 31, 2025
Results First Posted
January 31, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
We are bound by local Tanzanian guidelines regarding patient privacy and data security and are not allowed to share individual participant data without express permission of the Tanzanian National Institute for Medical Research.